Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2

MLA

Hai Yu, et al. “Targeting NEK2 Attenuates Glioblastoma Growth and Radioresistance by Destabilizing Histone Methyltransferase EZH2.” The Journal of Clinical Investigation, vol. 127, no. 8, June 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2382d8cd4989ae6ecee7b25843bda41e&authtype=sso&custid=ns315887.

APA

Hai Yu, Zhuo Zhang, Harley I. Kornblum, Ahmed Mohyeldin, Violaine Goidts, Jia Wang, Hong-yu Li, Dongquan Chen, Yong Jae Shin, Ichiro Nakano, Peng Cheng, Brendan Frett, Maode Wang, Sung Hak Kim, Wenhao Hu, Marat S. Pavlyukov, Do-Hyun Nam, Yeri Lee, Mutsuko Minata, & Wanfu Xie. (2016). Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2. The Journal of Clinical Investigation, 127(8).

Chicago

Hai Yu, Zhuo Zhang, Harley I. Kornblum, Ahmed Mohyeldin, Violaine Goidts, Jia Wang, Hong-yu Li, et al. 2016. “Targeting NEK2 Attenuates Glioblastoma Growth and Radioresistance by Destabilizing Histone Methyltransferase EZH2.” The Journal of Clinical Investigation 127 (8). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2382d8cd4989ae6ecee7b25843bda41e&authtype=sso&custid=ns315887.